Key result
Coronary embolism with AF linked to ~77% higher all-cause mortality versus non-CE AMI without AF.
Why the study?
Coronary embolism is an underrecognized cause of acute myocardial infarction in atrial fibrillation patients, and dedicated management guidelines are lacking due to limited evidence.
Does coronary embolism with atrial fibrillation increase the risk of all-cause mortality and ischemic stroke compared to non-CE AMI in patients with acute myocardial infarction?
Cohort (n=4,777)
No
Does coronary embolism with atrial fibrillation increase the risk of all-cause mortality and ischemic stroke compared to non-CE AMI in patients with acute myocardial infarction?
Coronary embolism in patients with atrial fibrillation represents a high-risk phenotype of acute myocardial infarction with significant residual thromboembolic risk despite therapeutic anticoagulation.
Answers are grounded in this paper and cite their sources.
Identifies CE with AF as high-risk AMI phenotype with residual thromboembolic risk; leaves open optimal prevention pending RCTs.
BACKGROUND: Coronary embolism (CE) is an underrecognized cause of acute myocardial infarction (AMI) in patients with atrial fibrillation (AF). Dedicated management guidelines are lacking because of limited evidence. METHODS: This retrospective cohort study leveraged routinely collected electronic health records and regional death registry data from a tertiary hospital in China (2014-2023). Among 4777 patients with AMI, CE was diagnosed using a 3-stage validation process: modified Shibata criteria, blinded angiographic core laboratory assessment, and final adjudication. Patients were categorized into 3 groups: CE with AF (n=78), non-CE AMI with AF (n=205), and non-CE AMI without AF (n=3937). Overlap weighting based on propensity scores was used to balance baseline covariates, and weighted Cox proportional hazards models with competing-risk analysis were applied for comparative outcome analyses. RESULTS: CE accounted for 1.6% (95% CI, 1.3%-2.0%) of all AMI cases and was present in 14.7% to 27.6% of AF-related AMI. Compared with non-CE AMI patients without AF, those with CE and AF had significantly higher risks of all-cause mortality (overlap-weighted hazard ratio [HR], 1.77 [95% CI, 1.15-2.71]) and ischemic stroke (overlap-weighted HR, 4.45 [95% CI, 2.34-8.45]), despite 79.2% receiving therapeutic anticoagulation. CONCLUSIONS: CE complicating AF represents a high-risk phenotype characterized by high residual thromboembolic risk despite anticoagulation. An integrated management strategy is proposed for future investigation, incorporating multimodal imaging, embolism-targeted reperfusion, and optimization of antithrombotic therapy, including standard-dose direct oral anticoagulants. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT06845956.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2026) conducted a cohort in Acute myocardial infarction and atrial fibrillation (n=4,777). Coronary embolism with atrial fibrillation vs. Non-coronary embolism AMI without atrial fibrillation was evaluated on All-cause mortality (HR 1.77, 95% CI 1.15-2.71). Coronary embolism with atrial fibrillation was associated with a significantly higher risk of all-cause mortality (HR 1.77; 95% CI 1.15-2.71) compared to non-CE AMI without AF.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: